Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Review Mississippi.
Press releases published on May 8, 2025
NKGen Biotech Chairman & CEO Paul Y. Song, M.D., Personally Invests $2.65 Million Cash to Accelerate Phase 2 Clinical Trial and Fulfill Financial Reporting Obligations
GlobeNewswire
·
May 8, 2025
New funding from Dr. Song augments $3.0 million in funding advances from AlpineBrook Capital in 2025 above and beyond the $5.5 million proceeds and additional $4 million commitments in previously-disclosed AlpineBrook convertible notes. SANTA ANA, Calif., …
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 8, 2025
-- Revenues increase 22% year over year driven by 90% growth in Zola® -- -- Arcadia sells patents for $750K and eliminates $1M in liabilities -- -- Roosevelt agreement amended to provide greater certainty regarding exchange ratio -- DALLAS, May 08, 2025 ( …
U.S. Online Shoppers Can Try on Their Next Fashion Purchase Using a 3D Avatar
GlobeNewswire
·
May 8, 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Online sizing technology provider, Makip, today announces a significant upgrade to its Unisize sizing recommendation engine. Using Unisize, online shoppers will now be presented with a 3D avatar of their unique …
TEN Launches First-Ever Fully On-Chain Poker Powered by Autonomous AI Agents
GlobeNewswire
·
May 8, 2025
- The launch of House of TEN introduces a new Web3 vertical with AI-native iGaming. Built on TEN’s encrypted Layer 2, it unlocks fully autonomous gameplay with programmable privacy, on-chain randomness, and zero off-chain logic. LONDON, May 08, 2025 (GLOBE …
Aligos Therapeutics Presents Positive Data at the EASL Congress 2025
GlobeNewswire
·
May 8, 2025
SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting
GlobeNewswire
·
May 8, 2025
PRINCETON, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and infectious …
Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights
GlobeNewswire
·
May 8, 2025
IND clearance and initiation of global basket trial exploring AlloNK® + rituximab in refractory rheumatoid arthritis, Sjögren’s disease, idiopathic inflammatory myopathies and systemic sclerosis First trial to explore an allogeneic cell therapy in …
Blue Mantis Expands Leadership Team to Drive Growth, Innovation and Market Impact
GlobeNewswire
·
May 8, 2025
PORTSMOUTH, N.H., May 08, 2025 (GLOBE NEWSWIRE) -- Blue Mantis, a leading provider of digital strategy and services specializing in managed services, cybersecurity and cloud solutions, today announced the appointments of Ruya Barrett as Chief Marketing …
ORYZON Awarded €13.26 Million Through the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)
GlobeNewswire
·
May 8, 2025
Approximately 15 million USD Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and orphan diseases Oryzon will explore Aggression in specific subsets of Autism Spectrum Disorder (ASD) to expand the precision …
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
GlobeNewswire
·
May 8, 2025
– EMA submission expected in 2H25 by partner Menarini – – PREVAIL Phase 3 CVOT remains on track – -- BROADWAY and TANDEM results presented at EAS with simultaneous publications in the New England Journal of Medicine and The Lancet, respectively -- -- …
FOREWARN to Provide Identity Verification Services to NEXUS Association of REALTORS® to Promote Agent Safety
GlobeNewswire
·
May 8, 2025
BOCA RATON, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that NEXUS Association of REALTORS® (“NEXUS”) will …
Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
·
May 8, 2025
Norwood, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fireside chat and one-on- …
Angry Shrimp Media Now ‘Go-To’ Growth Engine Builder for Founders and CEOs Scaling Smarter
GlobeNewswire
·
May 8, 2025
Cape Coral, Florida, May 08, 2025 (GLOBE NEWSWIRE) -- Angry Shrimp Media is redefining what smart scale looks like for today’s B2B leaders. Built for SaaS founders …
RAPT Therapeutics Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel …
Cassava Reports Q1 2025 Financials Results, Provides Business Update
GlobeNewswire
·
May 8, 2025
License agreement and recent leadership appointments position Cassava to advance development of simufilam in TSC-related epilepsy $117.3 Million in Cash and Cash Equivalents at March 31, 2025 AUSTIN, Texas, May 08, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences …
Core Molding Technologies Reports Fiscal 2025 First Quarter Results
GlobeNewswire
·
May 8, 2025
COLUMBUS, Ohio, May 08, 2025 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building …
VYNE Therapeutics Reports 2025 First Quarter Financial Results and Provides Business Update
GlobeNewswire
·
May 8, 2025
Repibresib gel (VYN201) Phase 2b vitiligo top-line results expected in mid-2025 Expected cash runway into 2H 2026 BRIDGEWATER, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage …
Glimpact Launches Global Impact Score – A Free Online Tool to Measure and Reduce the Environmental Footprint of Apparel, Revealing a New Vision of the Challenges of the Fashion Industry’s Ecological Transition
GlobeNewswire
·
May 8, 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Glimpact, the first platform for analyzing the overall systemic environmental impact of products and organizations, today launched Global Impact Score, North America’s first publicly accessible online tool to …
Cue Biopharma to Host Virtual Investor Event on May 15, 2025
GlobeNewswire
·
May 8, 2025
Mobilizing the Immune System: Cue Biopharma's Novel Biologics Portfolio Event Virtual Event will Feature Key Opinion Leaders Richard DiPaolo, PhD, and Andrew Cope, MD, PhD BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a …
Infinidat Wins 2025 Global InfoSec Awards for Cyber Resilience, Cyber Storage, and Ransomware Recovery from Cyber Defense Magazine
GlobeNewswire
·
May 8, 2025
WALTHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Infinidat, a leading provider of enterprise storage solutions, today announced that the company has won three Global InfoSec Awards from Cyber Defense Magazine, a leading information security magazine. The …